Clinical Trial Update: Concurrent Adjuvant Carboplatin and Accelerated Radiotherapy for Triple Negative Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial assessing concurrent adjuvant carboplatin with accelerated radiotherapy in triple negative breast cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)

Snippet

Sponsor: NYU Langone Health | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-01-12